Acadian Asset Management LLC Grows Position in Phreesia, Inc. $PHR

Acadian Asset Management LLC increased its position in shares of Phreesia, Inc. (NYSE:PHR) by 105.2% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 225,317 shares of the company’s stock after buying an additional 115,527 shares during the quarter. Acadian Asset Management LLC owned about 0.38% of Phreesia worth $5,754,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. KBC Group NV purchased a new position in Phreesia during the 1st quarter worth approximately $74,000. CWM LLC grew its stake in shares of Phreesia by 994.9% in the 1st quarter. CWM LLC now owns 4,040 shares of the company’s stock valued at $103,000 after purchasing an additional 3,671 shares during the last quarter. Smartleaf Asset Management LLC grew its stake in shares of Phreesia by 53.0% in the 1st quarter. Smartleaf Asset Management LLC now owns 5,267 shares of the company’s stock valued at $137,000 after purchasing an additional 1,825 shares during the last quarter. GAMMA Investing LLC grew its stake in shares of Phreesia by 10,605.7% in the 1st quarter. GAMMA Investing LLC now owns 5,674 shares of the company’s stock valued at $145,000 after purchasing an additional 5,621 shares during the last quarter. Finally, BNP Paribas Financial Markets purchased a new position in shares of Phreesia in the 4th quarter valued at approximately $163,000. Hedge funds and other institutional investors own 92.10% of the company’s stock.

Insider Activity at Phreesia

In other Phreesia news, General Counsel Allison C. Hoffman sold 1,245 shares of the company’s stock in a transaction that occurred on Thursday, July 17th. The stock was sold at an average price of $26.89, for a total transaction of $33,478.05. Following the sale, the general counsel owned 136,978 shares in the company, valued at $3,683,338.42. This represents a 0.90% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Mark Douglas Smith sold 7,000 shares of the company’s stock in a transaction that occurred on Wednesday, July 2nd. The shares were sold at an average price of $29.00, for a total value of $203,000.00. Following the sale, the director owned 37,353 shares in the company, valued at $1,083,237. The trade was a 15.78% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 109,292 shares of company stock valued at $3,295,323 over the last 90 days. Corporate insiders own 5.50% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have recently commented on the company. DA Davidson raised Phreesia to a “strong-buy” rating in a report on Monday, September 8th. Stephens reissued an “overweight” rating and issued a $32.00 price target on shares of Phreesia in a report on Wednesday, September 3rd. Raymond James Financial set a $33.00 price target on Phreesia and gave the company an “outperform” rating in a report on Friday, September 5th. Wall Street Zen raised Phreesia from a “hold” rating to a “buy” rating in a report on Sunday, June 1st. Finally, JMP Securities raised their price target on Phreesia from $30.00 to $34.00 and gave the company a “market outperform” rating in a report on Monday, September 8th. One investment analyst has rated the stock with a Strong Buy rating and twelve have assigned a Buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average price target of $34.08.

Phreesia Price Performance

Shares of NYSE:PHR opened at $24.20 on Friday. The company has a market cap of $1.45 billion, a P/E ratio of -57.62 and a beta of 0.72. The company has a quick ratio of 1.95, a current ratio of 2.12 and a debt-to-equity ratio of 0.02. Phreesia, Inc. has a 52 week low of $17.07 and a 52 week high of $32.76. The business has a fifty day simple moving average of $28.02 and a 200-day simple moving average of $26.46.

Phreesia (NYSE:PHR) last posted its quarterly earnings results on Thursday, September 4th. The company reported $0.01 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.07) by $0.08. Phreesia had a negative return on equity of 8.75% and a negative net margin of 5.35%.The firm had revenue of $117.26 million during the quarter, compared to the consensus estimate of $116.39 million. During the same quarter in the previous year, the business earned ($0.03) earnings per share. The firm’s quarterly revenue was up 14.9% compared to the same quarter last year. Phreesia has set its FY 2026 guidance at EPS. Equities research analysts forecast that Phreesia, Inc. will post -1.1 EPS for the current year.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.